Geron GERN
NASDAQ GERN
$1.52 -0.03 (-1.94%)
At close: Aug 21, 2026 · 4:00 PM EDT

Geron (GERN) Amortizatization of Intangibles (2010 - 2026)

Geron (GERN) posted Amortizatization of Intangibles of $1.1 million for Q1 2026, down 25.97% sequentially from $1.4 million in Q4 2025, and down 51.63% YoY from $2.2 million in Q1 2025.

Geron (GERN) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends

Geron has reported Amortizatization of Intangibles for 17 years, with the latest figure at $1.1 million in Q1 2026.

  • Quarterly Amortizatization of Intangibles fell 51.63% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 39.32% YoY) and the FY2025 annual result came in at $6.9 million, down 28.52% from the prior year.
  • Amortizatization of Intangibles slipped to $1.1 million in Q1 2026 per GERN's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Amortizatization of Intangibles peaked at $3.4 million in Q3 2023 and troughed at -$196000.0 in Q1 2022.
  • A 5-year average of $1.8 million and a median of $1.7 million in 2025 frame the typical range for Amortizatization of Intangibles.
  • The sharpest annual moves came in 2023 and 2026: Amortizatization of Intangibles jumped 3096.3% in 2023, then slumped 51.63% in 2026.
  • Over 5 years, Amortizatization of Intangibles stood at $956000.0 in 2022, then surged by 194.46% to $2.8 million in 2023, then declined by 14.67% to $2.4 million in 2024, then plunged by 39.88% to $1.4 million in 2025, then retreated by 25.97% to $1.1 million in 2026.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $1.1 million, $1.4 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Geron 1.02 Mn -299.83 Mn - 708,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 708,000.00
Jun 30, 2026 708,000.00
Mar 31, 2026 1.07 Mn
Mar 31, 2026 1.07 Mn
Dec 31, 2025 1.44 Mn
Dec 31, 2025 1.44 Mn
Sep 30, 2025 1.53 Mn
Sep 30, 2025 1.53 Mn
Jun 30, 2025 1.74 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 2.21 Mn
Mar 31, 2025 2.21 Mn
Dec 31, 2024 2.40 Mn
Dec 31, 2024 2.40 Mn
Sep 30, 2024 2.39 Mn
Sep 30, 2024 2.39 Mn
Jun 30, 2024 2.53 Mn
Jun 30, 2024 2.53 Mn
Mar 31, 2024 2.37 Mn
Mar 31, 2024 2.37 Mn